The FDA OKs Pfizer-BioNTech Booster For People 65+ Or At High Risk For Severe COVID

life-tips
Rufus Peoples receives a dose of the Pfizer-BioNTech COVID-19 vaccine at a vaccination clinic in Southfield, Mich., in August.

A third shot of the vaccine can be given at least six months after the two-dose regimen, according to the authorization. A booster rollout could begin this week.

(Image credit: Emily Elconin/Getty Images)

Share:

Post a Comment

Designed by OddThemes | Distributed by Blogger Themes